Paul Larocque

Paul Larocque is the President of Acerna Inc., a pharmaceutical, biological and medical device consultancy which provides good manufacturing practice and regulatory affairs services to a global clientele. For the past twelve years as a consultant, and previously in industry, Paul's focus was FDA compliance matters.

Previously, Paul held executive positions related to sterile products with Pfizer, SmithKline/Allergan and Eldan Pharmaceuticals. He also headed the unit responsible for the review of the chemistry and manufacturing parts of drug submissions at Health Canada. In addition, he chaired the industry committee that negotiated the sterile products chapter of GMP regulations at Health Canada.

He received his Bachelor of Science degree in Chemistry from the University of Ottawa. Mr. Larocque is a Chartered Chemist in Ontario, a Member of the Chemical Institute of Canada and was chosen for the Governor General's Study Group.

He was named a Fellow of The Organization for Professionals in Regulatory Affairs in Europe and has served on several trade association boards or committees; including a Chairmanship on the committee which negotiated Canadian GMP Guidelines. Mr. Larocque has twice been elected Chair of the Canadian Association of Professionals in Regulatory Affairs.

Courses:

• Aseptic Processing in the Manufacture of Biotech and Pharmaceutical Products